News / Africa

New Meningitis Vaccine a Success in Chad

A child receives a meningitis vaccination at the community center in El Daein, East Darfur, Sudan on October 8, 2012.
A child receives a meningitis vaccination at the community center in El Daein, East Darfur, Sudan on October 8, 2012.
Jennifer Lazuta
A study published this month in the Lancet medical journal found a new meningitis vaccine being used in Chad reduced the incidence of the disease by 94 percent.  According to the World Health Organization, meningitis affects nearly half a billion people living in sub-Saharan Africa each year and, even with proper treatment, is often deadly. 
 
Researchers say the first meningitis vaccine developed specifically for Africa has “dramatically reduced” the number of cases of the disease in Chad, as well as prevented its spread.
 
Dr. James Stuart, a professor at the London School of Hygiene and Tropical Medicine and a co-author of the study, said his team looked at the effects of what is known as MenAfriVac on 1.8 million people under the age of 29 across three regions in Chad during the 2012 meningitis epidemic.
 
"What we found was that the number of cases dropped dramatically in the part of the country that was vaccinated and that the meningitis epidemic continued in the part of the country that had not been vaccinated," Stuart said.  "So this, although it was not a trial, suggested that the vaccine had a very positive effect on protecting people against meningitis."

Stuart said MenAfriVac, which targets the type-A strain of the disease, completely prevented type A in all of the vaccinated regions.  It also reduced the incidence of all types of meningitis.  
 
According to the World Health Organization, more than one million cases of meningitis, which is the inflammation of the protective tissue that covers the brain and spinal cord, have been reported in Africa since 1988.
 
The highest incidence of the disease occurs in what is known as the “meningitis belt” of sub-Saharan Africa, a strip of 25 countries stretching from Senegal in the west to Ethiopia in the east.
 
No other meningitis vaccines have proven to be as effective as MenAfriVac, Stuart said.
 
"The new vaccine seems to stop people carrying the germ and it stops it therefore from being transmitted, whereas the old vaccine did not have an effect on carriage, so it did not stop the germ being transmitted between people," he said.  "So this new vaccine therefore has a double effect.  One is that it gives you a good individual protection against meningitis, and at the same time, it is actually stopping transmission, so it is actually preventing other people from getting meningitis as well."

Stuart said that such prevention is key when it comes to meningitis, as the disease can spread quickly, passing from person to person via bacteria that live in the throat.  Outbreaks in sub-Saharan Africa are common and have killed as many as 25,000 people at a time.
 
While this particular vaccine is not new, it was licensed in India in 2009 and introduced in Burkina Faso, Mali and Niger in December 2010, this was the first time researchers were able to test its effectiveness.

The World Health Organization says antibiotics are available as treatment, but meningitis can lead to serious health problems once contracted, including seizures, deafness, paralysis and brain damage, and that it results in death in about 10 percent of reported cases.  In Chad, the mortality rate has risen as high as 75 percent during outbreaks.
 
Stuart said that MenAfriVac will sell for less than 50 cents per dose in sub-Saharan Africa and can be included as part of routine preventative vaccinations for children.
 
While its longterm effects are still being studied, Stuart said there have been no indications of negative side effects.
 
Following its success in Chad, MenAfriVac has since been used to vaccinate an additional 100 million people against type A meningitis in sub-Saharan Africa.  Stuart said plans are underway to roll out the vaccine in the rest of the meningitis belt countries.

You May Like

US Investors Eye IPO for China's Alibaba

E-commerce giant handled 80 percent of China's online business last year, logging more Internet transactions than US-based Amazon.com and eBay combined More

Video Uneasy Calm Settles Over Israel, Gaza Strip

As cease-fire begins, Palestinians celebrate in streets; Israelis remain wary More

Video Chinese Doctors Use 3-D Spinal Implant

In treatment of a 12-year-old boy Chinese doctors used a 3-D printer and special software to create an exact replica of vertebra More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Chinese Doctors Use 3-D Spinal Implanti
X
August 27, 2014 4:53 PM
A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video Chinese Doctors Use 3-D Spinal Implant

A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video Uneasy Calm Settles Over Israel, Gaza Strip

Israel and the Gaza Strip have been calm since a cease-fire set in Tuesday evening, ending seven weeks of hostilities. Hamas, which controls Gaza, declared victory. Israelis were more wart. VOA’s Scott Bobb reports from Jerusalem.
Video

Video India’s Leprosy Battle Stymied by Continuing Stigma

Medical advancements in the treatment of leprosy have greatly diminished its impact around the world, largely eliminating the disease from most countries. India made great strides in combating leprosy, but still accounts for a majority of the world’s new cases each year, and the number of newly infected Indians is rising - more than 130,000 recorded last year. Doctors there say the problem has more to do with society than science. VOA News reports from Kolkata.
Video

Video Northern California Quake: No Way to Know When Next One Will Hit

A magnitude 6.0 earthquake rocked northern California’s Napa Valley on Sunday. Roads twisted and water mains burst. It was the wine country’s most severe quake in 15 years, and while hospitals treated many people, no one was killed. Arash Arabasadi has more from Washington on what the future may hold for those residents living on a fault line.
Video

Video Scientists Unlock Mystery of Bird Flocks

How can flocks of birds, schools of fish or herds of antelope suddenly change direction -- all the individuals adjusting their movement in concert, at seemingly the same time? British researchers now have some insights into this behavior, which has puzzled scientists for a long time. VOA's George Putic has more.
Video

Video Ukraine: Captured Troops Proof of Russian Role in Separatist Fight

Ukrainian officials say they have captured Russian soldiers on Ukrainian territory -- the latest accusation of Moscow's involvement in the conflict in eastern Ukraine. VOA's Gabe Joselow reports from the Ukrainian side of the battle, where soldiers are convinced of Russia's role.
Video

Video Rubber May Soon Come From Dandelions

Synthetic rubber has been around for more than a century, but quality tires for cars, trucks and aircraft still need up to 40 percent or more natural rubber content. As the source of natural rubber, the rubber tree, is prone to disease and can be affected by bad weather. So scientists are looking for replacements. And as VOA’s George Putic reports, they may have found one in a ubiquitous weed.
Video

Video Jewish Life in Argentina Reflected in Yiddish Tango

Jewish people from across Europe and Russia have been immigrating to Argentina for hundreds of years. They brought with them dance music that were eventually mixed with Argentine tango. The result is Yiddish tango -- a fusion of melodies and cultural experiences that is still evolving today. Elizabeth Lee reports from the Skirball Cultural Center in Los Angeles, where one band is bringing Yiddish tango to an American audience.

AppleAndroid